Meetings and publications
>> VHPB meetingsclick to go back to previous page  click to go forward to the next page  click to print this page

 

Viral Hepatitis  Prevention  Board

European  Liver Patients  Association

Meeting

 

Lucca,  Italy,  March 13-14, 2008

   

Prevention and Control of Viral Hepatitis :

The role and impact of patient and advocacy groups in and outside Europe.

 

 

Thursday, March 13, 2008

 

Session 1   Opening and objectives

 Chair:  Pierre Van Damme - Nadine Piorkowsky

     

09.00 - 09.30

Session 2   Viral hepatitis prevention in Europe

Chair: Pierre Van Damme - Nadine Piorkowsky

 

09.30 – 10.00    

Update on prevention and control of hepatitis B in WHO European Region. 1Mb (.pdf)

Liudmila Mosina (WHO/EURO) 

 

 

Session 3   Role and impact of patient and advocacy groups

Chair: Daniel Shouval – Paolo Bonanni

 

10.00 – 10.30    

Prevention and control of viral hepatitis; the role and impact of liver patient groups in Europe: general considerations. 309Kb (.pdf)

Nadine Piorkowsky (European Liver Patient Association)

 

10.30 – 11.00    

European patient groups for rare diseases. 810Kb (.pdf)

Michele Lipucci di Paola (European Organisation for rare diseases)

 

11.00 – 11.20     Coffee Break

 

11.20 – 11.50    

Prevention and control of viral hepatitis in the US; the National Viral Hepatitis Roundtable. 1.3Mb

Deborah Wexler (Immunization Action Coalition) 

 

11.50 – 12.10    

Relationship between industry and patient organisations: European Federation of Pharmaceutical industries and associations (EFPIA) ethical code. 512Kb (.pdf)

Luc Hessel (European Vaccine Manufactures)

 

12.10 – 13.30     Lunch

 

Session 4   Role and impact of patient and advocacy groups: country presentations

Chair : John Ward – Selim Badur

 

13.30 – 13.50    

Belgium: Carrefour Hιpatites-Aide et Contact // Vereniging voor hepatitis C patienten. 946 Kb (.pdf)

Muriel Colinet // Marie-Fabienne Van den Berghe

 

13.50 – 14.10    

Bulgaria: Hepasist. 5.9Mb (.pdf)

Stanimir Hasurdjiev

 

14.10 – 14.30    

Croatia: Hepatos. 356Kb (.pdf)

Tatjana Reic

 

14.30 -     14.50

Germany: Deutsche Leberhilfe. 54Kb (.pdf)

Achim Kautz

 

14.50 – 15.10    

Italy: EpaC. 635Kb (.pdf)

Ivan Gardini

 

15.10 -     15.30 Coffee Break

 

15.30 – 15.50    

Poland: Prometeuze. 75Kb (.pdf)

Ilona Sikorska

 

15.50 – 16.10    

The Netherlands : National Hepatitis Centre. 77Kb (.pdf)

Paula Van Leeuwen

 

16.10 – 16.20    

UK: British Liver Trust . 470Kb (.pdf)

Sarah Matthews

 

16.20 – 16.40    

US: The Hepatitis Foundation International. 62Kb (.pdf)

Thelma King Thiel

           

16.40 – 17.00    

Advocating for immigrant communities at risk. 1.3Mb (.pdf)

Samuel So

 

17.00 – 17.10    

Summary by the chairs and close of the day

 

 

 

Friday, March 14, 2008

 

 

Session 4   Role and impact of patient and advocacy groups: country presentations (continued)

Chair : Craig Shapiro – Wolfgang Jilg

 

 

08.30 – 08.50    

France: SOS Hepatites, National Federation.

Pascal Melin

 

 

Session 5   Initiatives to get attention and increase awareness on prevention and viral hepatitis

Chair: Craig Shapiro – Wolfgang Jilg

 

08.50 – 9.15     

The European Immunization Week. 857Kb (.pdf)

 Liudmila Mosina (WHO/EURO)

 

9.15 – 09.40     

World Hepatitis Day (WHD). 57Kb (.pdf)

Charles Gore

 

09.40 – 10.05    

Hepatitis B priority area for European policy; Call for action by the European Parliament. 82Kb (.pdf)

Charles Gore

 

10.05 – 10.20     Coffee break

 

 

 

 

Session 6A  ParalIel break-out session Group I 

Chair: Steven Wiersma – Daniel Lavanchy

     

10.20 – 11.30    

Topic: Identification of weaknesses; limitations and thresholds of  impact of patients groups on control and prevention of viral hepatitis

 

Session6B  ParalIel break-out session Group II

Chair: Franηoise Roudot-Thoraval - David Goldberg

     

10.20 – 11.30    

Topic: Identification strengths and opportunities of liver patients groups towards the control and prevention of viral hepatitis

 

Session 7   Feedback break-out sessions 

 

11.30 – 11.45     Report of Group I

 

11.45 – 12.00     Report of Group II

 

12.00 – 14.00     Lunch

 

Session 8   Conclusions of the meeting

Chair:  Johannes Hallauer – Nicole Guerin

     

14.00 - 15.00    

Presentation of the VHPB meeting conclusions. 76Kb (.pdf)

David FitzSimons

 

15.00 - 15.30     Discussion

 

15.30       Close of the meeting